drugset / Trial / NCT07560618
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Phase 4
Not yet recruiting
40 enrolled
Integrative Skin Science and Research
Arcutis Biotherapeutics, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.
Timeline
- Start
- 2026-04
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Roflumilast | Small molecule | 0.15 % | Topical |